APA (7th ed.) Citation

Li, S., Hamann, U., & Sutter, C. (2022). Cancer risks associated with BRCA1 and BRCA2 pathogenic variants. Journal of clinical oncology, 40(14), . https://doi.org/10.1200/JCO.21.02112

Chicago Style (17th ed.) Citation

Li, Shuai, Ute Hamann, and Christian Sutter. "Cancer Risks Associated with BRCA1 and BRCA2 Pathogenic Variants." Journal of Clinical Oncology 40, no. 14 (2022). https://doi.org/10.1200/JCO.21.02112.

MLA (9th ed.) Citation

Li, Shuai, et al. "Cancer Risks Associated with BRCA1 and BRCA2 Pathogenic Variants." Journal of Clinical Oncology, vol. 40, no. 14, 2022, https://doi.org/10.1200/JCO.21.02112.